Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment of High Risk Adult Acute Lymphoblastic Leukemia (LAL-AR/2003)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by PETHEMA Foundation
Sponsor:
Information provided by (Responsible Party):
PETHEMA Foundation
ClinicalTrials.gov Identifier:
NCT00853008
First received: February 25, 2009
Last updated: October 27, 2014
Last verified: October 2014